太多的药物，太多生病的澳大利亚老年人：共同努力是关键。
Too many pills, too many sick older Australians: Working together is key.
机构信息
PhD, MClinEpi, BPharm, Head of Research and Program Evaluation, Ward Medication Management, Vic; Research Fellow, Epidemiology, UniSA Clinical @ Health Sciences, University of South Australia, SA.
PhD, MSc Clin Pharm, BSc@(Hons) Pharm, AACPA, FSHP, Adv Pract Pharm, Head of Clinical Development, Ward Medication Management, Vic.
出版信息
Aust J Gen Pract. 2021 Mar;50(3):171-174. doi: 10.31128/AJGP-07-20-5548.
BACKGROUND
Australians living in aged care facilities are clinically complex, with multiple comorbidities treated with multiple medicines. Over the past 12 months, there has been unprecedented focus on harm from medications in aged care. This led the Australian Government to fund enhancements to the Residential Medication Management Review (RMMR) program.
OBJECTIVE
The aim of this article is to discuss how the enhanced RMMR program will address barriers and support general practitioners to make medication changes for older Australians.
DISCUSSION
These enhancements are intended to provide a complete cycle of care over nine months, with ongoing collaboration within the healthcare team including residents. This will allow a team approach to medication changes and monitoring resident response over time. Progress reports will provide a history of outcomes with respect to successful and unsuccessful medication changes. Successful outcomes for residents rely on the healthcare team working together.
背景
居住在养老院的澳大利亚人病情复杂，患有多种合并症，并接受多种药物治疗。在过去的 12 个月中，养老院的药物治疗带来的危害受到了前所未有的关注。这促使澳大利亚政府为住宅药物管理审查（RMMR）计划提供了资金支持。
目的
本文旨在讨论增强型 RMMR 计划如何克服障碍并支持全科医生为澳大利亚老年人调整药物治疗。
讨论
这些增强措施旨在在九个月内提供完整的护理周期，并在包括居民在内的医疗团队内进行持续协作。这将允许团队合作进行药物治疗调整，并随着时间的推移监测居民的反应。进展报告将提供与成功和不成功的药物调整相关的结果历史。居民的成功结果依赖于医疗团队的共同努力。
Zotero 插件